Manufacturing A World of Wellness

Global expertise in product development; producing quality, affordable pharmaceutical and healthcare products.

Click here to join our community

23 Default
25 Default
27 Default
29 Default
31 Default
33 Default
35 Default
51 Default
53 Default
55 Default
59 Default

All PuraCap Pharmaceutical prescription
brand products meet our rigorous standards
for quality, accessibility and ease of therapeutic delivery.

PuraCap International develops & markets prescription generic medications to meet patient needs for quality, efficacy and affordable products. PuraCap International is compromised of PuraCap Laboratories and PuraCab Caribe.

Our over the counter (OTC) business, Puravation Pharmaceuticals provides many top quality, OTC store brand &
private label products.

With our turn-key services, we can develop Prescription and OTC soft gelatin capsules in our state of the art facility, designed and constructed in accordance with all US FDA cGMP regulatory guidances.

71 Default
73 Default
75 Default

November 13, 2015

South Plainfield, NJ–November 11, 2015 – PuraCap Pharmaceutical LLC. is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated

May 19, 2014

Max Baucus, US Ambassador to China visits Wuhan Softgel Capsule Manufacturing Plant in Wuhan China
SOUTH PLAINFIELD, N.J., May 19, 2014 /PRNewswire/ — PuraCap Pharmaceutical today announced

Site Map

© 2016 PuraCap® Pharmaceutical LLC
All Rights Reserved.

This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries

PuraCap® Pharmaceutical LLC,
South Plainfield, NJ 07080.

U.S.A.
Phone: 908.941.5456
Fax: 908.941.5457

115 Default
117 Default
119 Default
121 Default
123 Default
125 Default
133 Default
135 Default
137 Default

Read about the US news & events that move PuraCap® Pharmaceutical forward.

PuraCap® News from our state-of-the-art manufacturing facilities, which is our affiliate company Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. located at Wuhan, China.

PuraCap® Pharmaceutical LLC Announces Acquisition of Blu Pharmaceuticals LLC and Blu Caribe

March 23, 2016

South Plainfield, NJ –PuraCap® Pharmaceutical LLC announced today the acquisition of Blu Pharmaceutical LLC and Blu Caribe Inc. creating PuraCap International LLC, a joint venture between PuraCap® and Dangdai International Group Co., Ltd. This acquisition will expand PuraCap’s world-class manufacturing expertise beyond soft gelatin capsules to include oral tablet & capsule dosage forms for the both the US and global markets.

153 Default

HumanWell PuraCap Pharmaceuticals Announces Successful FDA Inspection

PuraCap® Pharmaceutical LLC Announces Site Visit by US Ambassdor to China

161 Default
163 Default
165 Default
167 Default

Humanwell Healthcare Group and PuraCap® Pharmaceutical LLC To Acquire Epic Pharma, LLC

March 30, 2016

South Plainfield, NJ – Humanwell Healthcare Group and PuraCap® Pharmaceutical LLC announced today that the companies have entered into a definitive agreement to acquire 100% of the membership interests of Epic Pharma, LLC of Laurelton, NY for $550 million.  The acquisition will further establish Humanwell and PuraCap in the US generics market and expand their existing commercial and manufacturing capabilities.

173 Default

Manufacturing A World of Wellness

Global expertise in product development; producing quality, affordable pharmaceutical and healthcare products.

Click here to join our community

homeHOME

AS

All PuraCap Pharmaceutical prescription
brand products meet our rigorous standards
for quality, accessibility and ease of therapeutic delivery.

PuraCap International develops & markets prescription generic medications to meet patient needs for quality, efficacy and affordable products. PuraCap International is compromised of PuraCap Laboratories and PuraCab Caribe.

Our over the counter (OTC) business, Puravation Pharmaceuticals provides many top quality, OTC store brand &
private label products.

With our turn-key services, we can develop Prescription and OTC soft gelatin capsules in our state of the art facility, designed and constructed in accordance with all US FDA cGMP regulatory guidances.

November 16, 2015

South Plainfield, NJ– November 3, 2015 – PuraCap Pharmaceutical LLC
announced today the introduction of a
new product, EpiCeram-L™ Lip Care,
a unique lip care formulation with an
exclusive delivery

July 10, 2014

PuraCap™ Pharmaceutical Introduces
Unique EpiCeram® 225g Airless Pump
EpiCeram® Controlled Release Skin
Barrier Emulsion Now Offers Dosing
Flexibility with 2 Sizes.

November 13, 2015

South Plainfield, NJ–November 11, 2015 – PuraCap Pharmaceutical LLC. is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated

May 19, 2014

Max Baucus, US Ambassador to China visits Wuhan Softgel Capsule Manufacturing Plant in Wuhan China
SOUTH PLAINFIELD, N.J., May 19, 2014 /PRNewswire/ — PuraCap Pharmaceutical today announced

Site Map

© 2016 PuraCap® Pharmaceutical LLC
All Rights Reserved.

This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries

PuraCap® Pharmaceutical LLC,
South Plainfield, NJ 07080.

U.S.A.
Phone: 908.941.5456
Fax: 908.941.5457

Read about the US news & events that move PuraCap® Pharmaceutical forward.

PuraCap® News from our state-of-the-art manufacturing facilities, which is our affiliate company Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. located at Wuhan, China.

PuraCap® Pharmaceutical LLC Announces Acquisition of Blu Pharmaceuticals LLC and Blu Caribe

March 23, 2016

South Plainfield, NJ –PuraCap® Pharmaceutical LLC announced today the acquisition of Blu Pharmaceutical LLC and Blu Caribe Inc. creating PuraCap International LLC, a joint venture between PuraCap® and Dangdai International Group Co., Ltd. This acquisition will expand PuraCap’s world-class manufacturing expertise beyond soft gelatin capsules to include oral tablet & capsule dosage forms for the both the US and global markets.

PuraCap® Pharmaceutical LLC introduces new EpiCeram-L™ Lip Care

HumanWell PuraCap Pharmaceuticals Announces Successful FDA Inspection

PuraCap® Pharmaceutical LLC Announces Site Visit by US Ambassdor to China

Humanwell Healthcare Group and PuraCap® Pharmaceutical LLC To Acquire Epic Pharma, LLC

March 30, 2016

South Plainfield, NJ – Humanwell Healthcare Group and PuraCap® Pharmaceutical LLC announced today that the companies have entered into a definitive agreement to acquire 100% of the membership interests of Epic Pharma, LLC of Laurelton, NY for $550 million.  The acquisition will further establish Humanwell and PuraCap in the US generics market and expand their existing commercial and manufacturing capabilities.